Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 7
1982 37
1983 49
1984 56
1985 46
1986 66
1987 45
1988 56
1989 35
1990 37
1991 23
1992 24
1993 20
1994 17
1995 19
1996 8
1997 12
1998 10
1999 9
2000 12
2001 5
2002 9
2003 6
2004 10
2005 7
2006 11
2007 7
2008 17
2009 11
2010 14
2011 20
2012 28
2013 24
2014 28
2015 32
2016 40
2017 30
2018 16
2019 42
2020 50
2021 35
2022 44
2023 35
2024 38
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,105 results

Results by year

Filters applied: . Clear all
Page 1
Potential Anticancer Activity of Auranofin.
Onodera T, Momose I, Kawada M. Onodera T, et al. Chem Pharm Bull (Tokyo). 2019;67(3):186-191. doi: 10.1248/cpb.c18-00767. Chem Pharm Bull (Tokyo). 2019. PMID: 30827998 Free article. Review.
Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
Ndugire W, Raviranga NGH, Lao J, Ramström O, Yan M. Ndugire W, et al. Adv Healthc Mater. 2022 May;11(9):e2101032. doi: 10.1002/adhm.202101032. Epub 2021 Aug 5. Adv Healthc Mater. 2022. PMID: 34350709 Free PMC article.
Auranofin: Past to Present, and repurposing.
Yamashita M. Yamashita M. Int Immunopharmacol. 2021 Dec;101(Pt B):108272. doi: 10.1016/j.intimp.2021.108272. Epub 2021 Oct 29. Int Immunopharmacol. 2021. PMID: 34731781 Free article. Review.
[Potential Anticancer Activity of Auranofin].
Momose I, Onodera T, Kawada M. Momose I, et al. Yakugaku Zasshi. 2021;141(3):315-321. doi: 10.1248/yakushi.20-00179-2. Yakugaku Zasshi. 2021. PMID: 33642497 Free article. Review. Japanese.
Auranofin inhibits virulence pathways in Pseudomonas aeruginosa.
Yam JKH, Tan LZW, Hong Z, Salido MMS, Woo BY, Yong AMH, Tan CAZ, Li SFY, Yang L, Givskov M, Chng SS. Yam JKH, et al. Bioorg Med Chem. 2023 Feb 1;79:117167. doi: 10.1016/j.bmc.2023.117167. Epub 2023 Jan 12. Bioorg Med Chem. 2023. PMID: 36682225
Combatting Bacterial Persister cell infections by auranofin?
Asghari B, Sadeghi HR, Mazaherylaghab H. Asghari B, et al. Biomed Pharmacother. 2017 Dec;96:1565-1566. doi: 10.1016/j.biopha.2017.07.022. Epub 2017 Jul 14. Biomed Pharmacother. 2017. PMID: 28716566 No abstract available.
Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
Johnson SS, Liu D, Ewald JT, Robles-Planells C, Pulliam C, Christensen KA, Bayanbold K, Wels BR, Solst SR, O'Dorisio MS, Menda Y, Spitz DR, Fath MA. Johnson SS, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2382524. doi: 10.1080/15384047.2024.2382524. Epub 2024 Jul 25. Cancer Biol Ther. 2024. PMID: 39054566 Free PMC article.
Efficacy of auranofin as an inhibitor of desmoid progression.
Ito K, Nishida Y, Hamada S, Shimizu K, Sakai T, Ohkawara B, Alman BA, Enomoto A, Ikuta K, Koike H, Zhang J, Ohno K, Imagama S. Ito K, et al. Sci Rep. 2022 Jul 13;12(1):11918. doi: 10.1038/s41598-022-15756-9. Sci Rep. 2022. PMID: 35831372 Free PMC article.
1,105 results